
Cellestus Pharmaceuticals Private Limited
About Cellestus Pharmaceuticals Private Limited
Data last updated:
Cellestus Pharmaceuticals Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24232HP2014PTC000736. Its GSTIN is 02AAFCC7303Q1ZM (Himachal Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kiran Devi and Manoj Kumar Shahi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vill. Kalyanpur Chakkan Road Tehsil – Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.11 Cr, a growth of 122% compared to the previous year. For the same year it recorded a net profit of ₹58,388 (net margin 0.5%) and EBITDA of ₹3.16 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹27 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressVill. Kalyanpur Chakkan Road Tehsil – Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cellestus Pharmaceuticals Private Limited
The main business activity of Cellestus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cellestus Pharmaceuticals Private Limited FY 2025 filings available
Cellestus Pharmaceuticals Private Limited reported revenue of ₹1.11 Cr (up 122% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Cellestus Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 122% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cellestus Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.16 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹58,388 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cellestus Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cellestus Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cellestus Pharmaceuticals Private Limited
Cellestus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Uro Medics Private Limited | ₹1.12 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Ernakulam, Kerala, India |
| Tricent Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | •••• | •••• | 7056835.0% | •••• | Lucknow, Uttar Pradesh, India |
| Cosdvl Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Nuevo Therapeutics Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Shivaste Traders Private Limited | ₹1.11 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Greater Noida West, Uttar Pradesh, India |
| Cellestus Pharmaceuticals Private Limited this company | ₹1.11 Cr (FY 2024) | •••• | •••• | 122.0% | •••• | Baddi, Himachal Pradesh, India |
| Nikhi Health Care Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Davanagere, Karnataka, India |
| Quantrix Healthcare Private Limited | ₹1.11 Cr (FY 2020) | •••• | •••• | -34.0% | •••• | Indore, Madhya Pradesh, India |
| New Search Life Sciences Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Radmex Healthcare Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 1258.0% | •••• | New Delhi, Delhi, India |
| Saudavel Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Margao, Goa, India |
Peers are the five companies nearest above and the five nearest below Cellestus Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Cellestus Pharmaceuticals Private Limited
Cellestus Pharmaceuticals Private Limited is audited by DKBS AND COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DKBS AND COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Cellestus Pharmaceuticals Private Limited
Cellestus Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Devi | Director | 31 Jul 2018 | 8 Years 2 Months | Current |
| Manoj Kumar Shahi | Director | 24 Jul 2014 | 12 Years 2 Months | Current |
Ownership and Shareholding of Cellestus Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cellestus Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2024 | Hdfc Bank Limited | ₹17 Lakh | Open |
| 28 Aug 2019 | Others | ₹10 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Cellestus Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Cellestus Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cellestus Pharmaceuticals Private Limited
Cellestus Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Kiran Devi was appointed as Director on 31 Jul 2018.
Credit Ratings, Litigation & Regulatory Alerts for Cellestus Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cellestus Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cellestus Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cellestus Pharmaceuticals Private Limited
Cellestus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAFCC7303Q1ZM | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cellestus Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellestus Pharmaceuticals Private Limited
Cellestus Pharmaceuticals is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 July 2014 (12+ years old) and is registered under CIN U24232HP2014PTC000736.
Cellestus Pharmaceuticals reported revenue of ₹1.11 Cr for FY 2024 (up 122% YoY).
Cellestus Pharmaceuticals has 2 current directors:
- Kiran Devi - Director
- Manoj Kumar Shahi - Director
Cellestus Pharmaceuticals reported a net profit of ₹58,388 (net margin 0.5%) and EBITDA of ₹3.16 Lakh (EBITDA margin 2.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cellestus Pharmaceuticals is 55% over three years and 23% over five years. In the latest year (FY 2024) revenue rose 122%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cellestus Pharmaceuticals is 02AAFCC7303Q1ZM, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Cellestus Pharmaceuticals is U24232HP2014PTC000736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellestus Pharmaceuticals was incorporated on 24 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Cellestus Pharmaceuticals by revenue are Uro Medics Private Limited, Tricent Pharmaceuticals Private Limited, Cosdvl Pharmaceuticals Private Limited, Nuevo Therapeutics Private Limited, Shivaste Traders Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Kiran Devi was appointed as Director on 31 Jul 2018. Raghavendra Chaturvedi ceased to be Director on 25 Jul 2018. Manoj Kumar Shahi was appointed as Director on 24 Jul 2014.
The registered office of Cellestus Pharmaceuticals is at Vill. Kalyanpur Chakkan Road Tehsil – Baddi, Himachal Pradesh, India – 173205.